Replimune (REPL) Non-Current Debt (2023 - 2026)
Replimune (REPL) posted Non-Current Debt of $84.11 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 79.8% from $46.79 million a year earlier and up 1.0% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Non-Current Debt (2023 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Replimune's Non-Current Debt came in at $83.31 million, up 79.6% from FY2025.
- Annual Non-Current Debt has increased for three consecutive fiscal years, with a three-year compound annual growth rate of 42.7% (FY2023 to FY2026).
- In prior fiscal years, Replimune's Non-Current Debt was $46.38 million in FY2025 (+3.5%), $44.81 million in FY2024 (+56.4%) and $28.65 million in FY2023.
- The fiscal Q1 2027 figure stands as the highest quarterly Non-Current Debt in data going back to fiscal Q4 2023.
- On a year-over-year basis, Non-Current Debt has increased in each of the last six quarters, with growth averaging 28.9% over the last six quarters.
- According to Business Quant data, Non-Current Debt for the three prior fiscal quarters was $83.31 million (Q4 2026), $47.63 million (Q3 2026) and $47.21 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.92 Bn | 1,105.50 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 617.57 Bn | 536.10 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 501.37 Bn | 474.48 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 367.96 Bn | 322.33 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 297.98 Bn | 261.97 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.14 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 236.30 Bn | 191.70 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 190.27 Bn | 164.46 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 169.65 Bn | 116.29 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Replimune | 1.13 Bn | 69.54 Mn | - | 84.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 84.11 Mn |
| Mar 31, 2026 | 83.31 Mn |
| Dec 31, 2025 | 47.63 Mn |
| Sep 30, 2025 | 47.21 Mn |
| Jun 30, 2025 | 46.79 Mn |
| Mar 31, 2025 | 46.38 Mn |
| Dec 31, 2024 | 45.96 Mn |
| Sep 30, 2024 | 45.57 Mn |
| Jun 30, 2024 | 45.19 Mn |
| Mar 31, 2024 | 44.81 Mn |
| Mar 31, 2023 | 28.65 Mn |
API Access
Replimune Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();